Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

The forefront of technology innovation

How regulatory process innovation risks overpromising with AI

Blueberry Therapeutics receives clearance from the FDA to proceed with the clinical investigation of BB2603

Blueberry Therapeutics has received an investigational new drug (IND) clearance from the Food and Drug Administration (FDA) to proceed with the clinical development of BB2603

Onyx Health

Empowering and equipping medical affairs teams to embrace an ever-expanding remit

Written by Jess Ingram and Francisca Costa, OPEN Health

OPEN Health

- PMLiVE

Givlaari, Rybelsus lead crowded CHMP recommendations

EU regulator delivered 15 positive opinions and no rejections

- PMLiVE

GSK and Gilead join global efforts to tackle novel coronavirus

Confirmed cases rise to over 17,000 in China

- PMLiVE

Aimmune’s Palforzia is first peanut allergy drug cleared in US

Shares in the Nasdaq-listed biotech have spiked

Rethinking Electronic Medical Records

EMR systems are far from perfect. Clinician and PhD candidate Dr. Pao takes us through his perspective on the system and how he aims to lead the way by solving...

Blue Latitude Health

Bristol Myers Squibb logo

Another blow for BMS in first-line NSCLC as it pulls EU filing

Opdivo/Yervoy combination is still under review with the FDA

- PMLiVE

Q&A: Stefi Rucci

PME interviews SAY Communications' joint MD and Director of Healthcare

- PMLiVE

PM Society announces new co-chairs for 2020

Caroline Benson and Colin Williams will succeed Craig Bradley

Blue Latitude Health moves to new offices in New York

Blue Latitude Health has moved offices to a new location in New York following a year of substantial growth.

Blue Latitude Health

Top five digital design tips for healthcare companies

Getting the right digital design is essential for healthcare and pharma companies, here are the five things I think all businesses should consider

Onyx Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links